Analyses of the MAPT, PGRN, and C9orf72 mutations in Japanese patients with FTLD, PSP, and CBS
Kotaro Ogaki(Juntendo University), Nobutaka Hattori(RIKEN Center for Brain Science), Yasumasa Kokubo(Mie University), Kei‐ichi Ishikawa(Tokyo University of the Arts), Takashi Nonaka(Tokyo Metropolitan Institute of Medical Science), Tomonori Kobayashi(Juntendo University), Masashi Takanashi(Juntendo University), Hisamasa Imai(Tokyo Rinkai Hospital), Yumiko Motoi(Juntendo University), Masato Hasegawa(Tokyo Institute of Psychiatry), Yuanzhe Li(Juntendo University), Ryogen Sasaki(Mie University), Tetsuro Tsukamoto(Numazu City Hospital), Hiroyuki Tomiyama(German Center for Neurodegenerative Diseases), Masahiko Kishi(Toho University Medical Center Sakura Hospital), Shigeki Kuzuhara(Suzuka University of Medical Science), Hiroyo Yoshino(Juntendo University), Keiichi Shioya(National Hospital Organization Miyazaki Higashi Hospital), Masayuki Yokochi(Ebara Hospital), Manabu Funayama(Juntendo University)
Cited by 93
Related Papers
Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
|Nature Genetics|2000|2k
PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy
|The Journal of Cell Biology|2010|1.9k